AI matched optical heart maps in six porcine hearts—but patient benefit is untested
A Japanese system reconstructed complex atrial conduction from catheter signals, then showed different patterns in 12 patients. It has not yet guided treatment or improved outcomes.
The short version
- What happened
- The convolutional network was trained on 13,824 simulated samples, then compared with optical mapping in six ex vivo porcine hearts.
- Who it affects
- More informative mapping might eventually help personalise atrial-fibrillation ablation, but this study does not show that patients receive safer procedures or fewer recurrences.
- What remains unproven
- Only six ex vivo porcine hearts and 12 retrospective patient records
Keep in mind
Only six ex vivo porcine hearts and 12 retrospective patient records
No clinical optical-mapping reference or prospective treatment comparison
No recurrence, safety or patient-outcome endpoint
Equity, directorship, patent and proprietary-method interests
Source analysis · 1 linked source. Primary analysed source date: 25 October 2026.
Read the full report · 3 min The evidence, methods, implications and limitations
The model reconstructed conduction without marking local activation times
Researchers trained Deep-learning-based Electrode Action Potential Mapping, or DEAP Mapping, on 13,824 simulated examples from a fibrotic human-atrial model. The aim was to reconstruct membrane-potential patterns directly from unipolar intracardiac electrograms, avoiding the local activation-time annotations that become unreliable during complex conduction.
In six isolated porcine hearts, optical fluorescence mapping supplied the comparator. Phase-variance maps from DEAP Mapping reached mean structural similarity of 0.87 with a 0.07 standard deviation, compared with 0.36 ± 0.14 for conventional activation maps. That supports technical reconstruction under controlled ex vivo conditions.[1]
Twelve patient records show feasibility, not a treatment advantage
The team then applied the system retrospectively to catheter recordings from 12 people with non-paroxysmal atrial fibrillation. It produced spatially continuous patterns of conduction heterogeneity that partly differed from existing maps and varied between patients. There was no patient-level optical reference, however, and the study did not use those maps to choose ablation sites.
The next step is a prospective, multi-centre study comparing predefined targeting strategies and measuring recurrence, procedure time and complications. Two authors hold equity in and direct OpMap Inc.; four authors are named inventors, and one signal-processing step is proprietary. Those interests do not invalidate the result, but they raise the value of independent replication.[1]
The distinction that matters
The validation ladder
The evidence moves from simulation to controlled tissue and then to a small retrospective clinical series.
Simulation
Train on 13,824 modelled samples
Learns conduction patterns
Porcine hearts
Compare with optical mapping in six hearts
SSIM 0.87 ± 0.07
Patients
Apply retrospectively in 12 people
Feasibility only